Published in J Hematop on April 16, 2008
Elevated Cancer-Specific Mortality Among HIV-Infected Patients in the United States. J Clin Oncol (2015) 2.40
Cytokines and chemokines at the crossroads of neuroinflammation, neurodegeneration, and neuropathic pain. Mediators Inflamm (2013) 1.43
Neuronal toxicity in HIV CNS disease. Future Virol (2012) 0.85
The role of the tumor microenvironment in HIV-associated lymphomas. Biomark Med (2015) 0.77
New developments in the pathology of malignant lymphoma: a review of the literature published from May to July 2008. J Hematop (2008) 0.76
Tumorigenesis and the angiogenic switch. Nat Rev Cancer (2003) 11.95
Role of the Flt-1 receptor tyrosine kinase in regulating the assembly of vascular endothelium. Nature (1995) 9.84
Vascular permeability factor/vascular endothelial growth factor: a critical cytokine in tumor angiogenesis and a potential target for diagnosis and therapy. J Clin Oncol (2002) 7.76
Expression of vascular endothelial growth factor and its receptor, KDR, correlates with vascularity, metastasis, and proliferation of human colon cancer. Cancer Res (1995) 4.84
The cell cycle: a review of regulation, deregulation and therapeutic targets in cancer. Cell Prolif (2003) 4.68
Synergy between basic fibroblast growth factor and HIV-1 Tat protein in induction of Kaposi's sarcoma. Nature (1994) 3.05
VEGF is an essential mediator of the neurogenic and behavioral actions of antidepressants. Proc Natl Acad Sci U S A (2007) 2.22
VEGF receptor signaling in tumor angiogenesis. Oncologist (2000) 1.94
Structural and functional specificities of PDGF-C and PDGF-D, the novel members of the platelet-derived growth factors family. FEBS J (2005) 1.92
Expression of VEGF(xxx)b, the inhibitory isoforms of VEGF, in malignant melanoma. Br J Cancer (2007) 1.75
The angiogenesis induced by HIV-1 tat protein is mediated by the Flk-1/KDR receptor on vascular endothelial cells. Nat Med (1996) 1.72
Interferon alpha and Tat involvement in the immunosuppression of uninfected T cells and C-C chemokine decline in AIDS. Proc Natl Acad Sci U S A (1998) 1.68
Vascular endothelial growth factor (VEGF) as a target of bevacizumab in cancer: from the biology to the clinic. Curr Med Chem (2006) 1.59
Vascular permeability factor/vascular endothelial growth factor: an important mediator of angiogenesis in malignancy and inflammation. Int Arch Allergy Immunol (1995) 1.55
Structure of a VEGF-VEGF receptor complex determined by electron microscopy. Nat Struct Mol Biol (2007) 1.48
Microvessel density, vascular endothelial growth factor and its receptors Flt-1 and Flk-1/KDR in hepatocellular carcinoma. Am J Clin Pathol (2001) 1.39
The enigmas of Kaposi's sarcoma. Science (1998) 1.39
Angiopoietins, growth factors, and vascular morphology in early arthritis. J Rheumatol (2003) 1.38
VEGF and VEGFR-2 (KDR) internalization is required for endothelial recovery during wound healing. Exp Cell Res (2007) 1.32
Microvessel density and expression of vascular endothelial growth factor and its receptors in diffuse large B-cell lymphoma subtypes. Am J Pathol (2007) 1.30
Inhibition of angiogenesis in vivo and growth of Kaposi's sarcoma xenograft tumors by the anti-malarial artesunate. Biochem Pharmacol (2004) 1.28
Clinical experience with angiogenesis signaling inhibitors: focus on vascular endothelial growth factor (VEGF) blockers. Cancer Control (2002) 1.25
Strong expression of kinase insert domain-containing receptor, a vascular permeability factor/vascular endothelial growth factor receptor in AIDS-associated Kaposi's sarcoma and cutaneous angiosarcoma. Am J Pathol (1996) 1.23
HIV-tat protein is a heparin-binding angiogenic growth factor. Oncogene (1996) 1.18
Vascular permeability induced by VEGF family members in vivo: role of endogenous PAF and NO synthesis. J Cell Biochem (2007) 1.13
Angiogenic effects of extracellular human immunodeficiency virus type 1 Tat protein and its role in the pathogenesis of AIDS-associated Kaposi's sarcoma. Clin Microbiol Rev (2002) 1.12
Physical interaction between CDK9 and B-Myb results in suppression of B-Myb gene autoregulation. Oncogene (2000) 1.10
HIV-1 Tat protein and endothelium: from protein/cell interaction to AIDS-associated pathologies. Angiogenesis (2002) 1.07
RB2/p130 gene-enhanced expression down-regulates vascular endothelial growth factor expression and inhibits angiogenesis in vivo. Cancer Res (2001) 0.97
Signalling properties of an HIV-encoded angiogenic peptide mimicking vascular endothelial growth factor activity. Biochem J (2001) 0.92
Modulation of growth factor action: implications for the treatment of cardiovascular diseases. Circulation (1997) 0.92
Expression of RB2/p130 tumor-suppressor gene in AIDS-related non-Hodgkin's lymphomas: implications for disease pathogenesis. Hum Pathol (2002) 0.91
Kaposi's sarcoma cells of different etiologic origins respond to HIV-Tat through the Flk-1/KDR (VEGFR-2): relevance in AIDS-KS pathology. Biochem Biophys Res Commun (2000) 0.90
Angiogenesis measured by expression of CD34 antigen in lymph nodes of patients with non-Hodgkin's lymphoma. Folia Histochem Cytobiol (2004) 0.87
Augmentation of vascular permeability of VEGF is enhanced by KDR-binding proteins. Biochem Biophys Res Commun (2007) 0.85
Targeted inhibition of angiogenic factors in AIDS-related disorders. Curr Drug Targets Infect Disord (2003) 0.84
The splice variants 120 and 164 of the angiogenic peptide vascular endothelial cell growth factor (VEGF) are expressed during Achilles tendon healing. Arch Orthop Trauma Surg (2003) 0.83
HIV-1 detection by nested PCR and viral culture in fresh or cryopreserved postmortem skin: potential implications for skin handling and allografting. J Clin Pathol (1997) 0.82
EDF-1, a novel gene product down-regulated in human endothelial cell differentiation. J Biol Chem (1998) 0.81
New therapies for the treatment of AIDS-related Kaposi sarcoma. Curr Opin Oncol (2000) 0.79
VEGF-D is expressed in activated lymphoid cells and in tumors of hematopoietic and lymphoid tissues. Leuk Lymphoma (2007) 0.77
Influence of the epithelium on responsiveness of guinea-pig isolated trachea to contractile and relaxant agonists. Br J Pharmacol (1986) 2.07
Low versus high cell turnover in diffusely growing non-Hodgkin's lymphomas. J Pathol (1995) 2.03
Antigen retrieval techniques in immunohistochemistry: comparison of different methods. J Pathol (1997) 2.01
In vitro responsiveness of human asthmatic bronchus to carbachol, histamine, beta-adrenoceptor agonists and theophylline. Br J Clin Pharmacol (1986) 1.73
HIV-associated malignant lymphomas in Kenya (Equatorial Africa) Hum Pathol (1998) 1.66
A case-control study of the relation between plasma selenium and asthma in European populations: a GAL2EN project. Allergy (2008) 1.66
EuroClonality/BIOMED-2 guidelines for interpretation and reporting of Ig/TCR clonality testing in suspected lymphoproliferations. Leukemia (2012) 1.60
Diffuse centrocytic and/or centroblastic malignant non-Hodgkin's lymphomas: comparison of mitotic and pyknotic (apoptotic) indices. Int J Cancer (1991) 1.53
MYC translocation-negative classical Burkitt lymphoma cases: an alternative pathogenetic mechanism involving miRNA deregulation. J Pathol (2008) 1.52
Hodgkin's lymphoma: the pathologist's viewpoint. J Clin Pathol (2002) 1.51
Mutations in the retinoblastoma-related gene RB2/p130 in lung tumors and suppression of tumor growth in vivo by retrovirus-mediated gene transfer. Cancer Res (2000) 1.45
A ten-year experience in control of poliomyelitis through a combination of live and killed vaccines in two developing areas. Am J Public Health (1989) 1.44
Tubuloreticular inclusions and viral particles in a case of hairy cell leukemia. Haematologica (1989) 1.39
Fatal cardiac arrhythmia after infusion of dimethyl sulfoxide-cryopreserved hematopoietic stem cells in a patient with severe primary cardiac amyloidosis and end-stage renal failure. Ann Hematol (2000) 1.32
Update on extranodal lymphomas. Conclusions of the Workshop held by the EAHP and the SH in Thessaloniki, Greece. Histopathology (2006) 1.28
Peripheral T-cell lymphomas. Clinico-pathologic study of 168 cases diagnosed according to the R.E.A.L. Classification. Ann Oncol (1997) 1.26
Smooth muscle cells of the media in the dilatative pathology of ascending thoracic aorta: morphology, immunoreactivity for osteopontin, matrix metalloproteinases, and their inhibitors. Hum Pathol (2001) 1.21
Factors predicting the persistence of genital human papillomavirus infections and PAP smear abnormality in HIV-positive and HIV-negative women during prospective follow-up. Int J STD AIDS (2003) 1.17
Burkitt's lymphoma: new insights into molecular pathogenesis. J Clin Pathol (2003) 1.14
Adenosine receptors and asthma. Br J Pharmacol (2008) 1.14
Role of sex hormones in allergic inflammation in mice. Clin Exp Allergy (2007) 1.14
VATS for congenital lobar emphysema: a case report. Minerva Chir (2009) 1.12
Heterogeneous nuclear expression of the promyelocytic leukemia (PML) protein in normal and neoplastic human tissues. Am J Pathol (1996) 1.11
Regulation of HIV-1 long terminal repeats by interaction of C/EBP(NF-IL6) and NF-kappaB/Rel transcription factors. J Biol Chem (1996) 1.07
Distribution and ecological relevance of fine sediments in organic-enriched lagoons: the case study of the Cabras lagoon (Sardinia, Italy). Mar Pollut Bull (2008) 1.07
Immunohistochemical co-localization of transient receptor potential vanilloid (TRPV)1 and sensory neuropeptides in the guinea-pig respiratory system. Neuroscience (2006) 1.07
Inhibition of miR-9 de-represses HuR and DICER1 and impairs Hodgkin lymphoma tumour outgrowth in vivo. Oncogene (2012) 1.06
The endogenous cannabinoid agonist, anandamide stimulates sensory nerves in guinea-pig airways. Br J Pharmacol (2001) 1.05
Diffuse large B-cell lymphoma: one or more entities? Present controversies and possible tools for its subclassification. Histopathology (2002) 1.03
Deficient processing and activity of type I insulin-like growth factor receptor in the furin-deficient LoVo-C5 cells. Endocrinology (1998) 1.03
Classification of beta-adrenoceptors in human isolated bronchus. Br J Pharmacol (1984) 1.03
Burkitt's lymphomas express VH genes with a moderate number of antigen-selected somatic mutations. Am J Pathol (1995) 1.02
The pathologist's view point. Part I--indolent lymphomas. Haematologica (2000) 1.02
Nociceptin inhibits non-adrenergic non-cholinergic contraction in guinea-pig airway. Br J Pharmacol (1998) 1.02
The orthopaedic aspects of mycetoma. Bone Joint J (2014) 1.02
Role of the interaction between large T antigen and Rb family members in the oncogenicity of JC virus. Oncogene (2006) 1.01
Genetic alterations disrupting the nuclear localization of the retinoblastoma-related gene RB2/p130 in human tumor cell lines and primary tumors. Cancer Res (2000) 0.99
RB2/p130 gene-enhanced expression down-regulates vascular endothelial growth factor expression and inhibits angiogenesis in vivo. Cancer Res (2001) 0.97
PAF-induced bronchial hyperresponsiveness in the rabbit: contribution of platelets and airway smooth muscle. Br J Pharmacol (1990) 0.97
Shc mediates IL-6 signaling by interacting with gp130 and Jak2 kinase. J Immunol (1997) 0.97
The effects of HIV-1 Tat protein on cell cycle during cervical carcinogenesis. Cancer Biol Ther (2006) 0.96
Nonclostridial gas gangrene. J Foot Surg (1990) 0.96
Early lung growth and chronic airflow obstruction. Thorax (1994) 0.95
Asthma in Gaza refugee camp children and its relationship with house dust mites. Ann Allergy (1994) 0.95
Measles in Israel, the West Bank, and Gaza: continuing incidence and the case for a new eradication strategy. Rev Infect Dis (1990) 0.94
The XLMR gene ACSL4 plays a role in dendritic spine architecture. Neuroscience (2008) 0.94
Inhibition of CD11-CD18 complex prevents acute lung injury and reduces mortality after peritonitis in rabbits. Am J Respir Crit Care Med (2000) 0.93
Epstein-Barr nuclear antigen 1 induces expression of the cellular microRNA hsa-miR-127 and impairing B-cell differentiation in EBV-infected memory B cells. New insights into the pathogenesis of Burkitt lymphoma. Blood Cancer J (2012) 0.93
Sediment characteristics and macrofauna distribution along a human-modified inlet in the Gulf of Oristano (Sardinia, Italy). Mar Pollut Bull (2007) 0.91
Regulatory functions of Cdk9 and of cyclin T1 in HIV tat transactivation pathway gene expression. J Cell Biochem (1999) 0.91
Elevated expression of adenosine A1 receptor in bronchial biopsy specimens from asthmatic subjects. Eur Respir J (2007) 0.91
Pyothorax-associated lymphoma: description of the first two cases detected in Italy. Ann Oncol (1997) 0.91
Long pedunculated colonic polyp with diverticulosis: case report and review of the literature. Pathologica (2011) 0.91
Chronic progressive leptomeningitis associated with measles virus. Lancet (1997) 0.91
Role of cytokines and chemokines in bronchial hyperresponsiveness and airway inflammation. Pharmacol Ther (2002) 0.91
Effect of Mycobacterium tuberculosis chaperonins on bronchial eosinophilia and hyper-responsiveness in a murine model of allergic inflammation. Clin Exp Allergy (2004) 0.90
Inhibition of neuroblastoma-induced angiogenesis by fenretinide. Int J Cancer (2001) 0.89
Immunohistochemistry of bone-marrow biopsy. Leuk Lymphoma (1997) 0.89
Discovering the causes of atopy. BMJ (1997) 0.89
Methicillin resistance and vancomycin heteroresistance in Staphylococcus aureus in cystic fibrosis patients. Eur J Clin Microbiol Infect Dis (2010) 0.89
A novel animal model for investigating persistent airway hyperresponsiveness. J Pharmacol Toxicol Methods (1993) 0.89
Pathologic aspects of AIDS malignancies. Oncogene (2003) 0.88
Angiogenesis and anti-angiogenesis in neuroblastoma. Eur J Cancer (2002) 0.88
Retinoblastoma-related p107 and pRb2/p130 proteins in malignant lymphomas: distinct mechanisms of cell growth control. Clin Cancer Res (1999) 0.88
Performance of cytology and colposcopy in diagnosis of cervical intraepithelial neoplasia (CIN) in HIV-positive and HIV-negative women. Cytopathology (2001) 0.87
Phosphodiesterase inhibitors in the treatment of inflammatory diseases. Handb Exp Pharmacol (2011) 0.87
Dose-related effects of formoterol on airway responsiveness to adenosine 5'-monophosphate and histamine. Eur Respir J (2002) 0.87
Assessment of response to chemoradiation therapy in rectal cancer using MR volumetry based on diffusion-weighted data sets: a preliminary report. Radiol Med (2012) 0.87
The use of bronchodilators in stable chronic obstructive pulmonary disease. Pulm Pharmacol Ther (1997) 0.87
Genetic alterations of the retinoblastoma-related gene RB2/p130 identify different pathogenetic mechanisms in and among Burkitt's lymphoma subtypes. Am J Pathol (2000) 0.86
Randomized trial of daily versus weekly administration of 2-chlorodeoxyadenosine in patients with hairy cell leukemia: a multicenter phase III trial (SAKK 32/98). Leuk Lymphoma (2009) 0.86
pRb2/p130 and p107 control cell growth by multiple strategies and in association with different compartments within the nucleus. J Cell Physiol (2001) 0.86
Hereditary diffuse gastric cancer and E-cadherin: description of the first germline mutation in an Italian family. Eur J Surg Oncol (2006) 0.86
Neoplastic cells of Hodgkin's disease show differences in EBV expression between Kenya and Italy. Int J Cancer (1996) 0.85
Different patterns of cell proliferation and death and oncogene expression in cutaneous malignant melanoma. J Cutan Pathol (1998) 0.85
Revised European-American Lymphoma Classification. Curr Opin Oncol (1995) 0.85
Cytokeratin-positive interstitial cell neoplasm: a case report and classification issues. Histopathology (2003) 0.85
A survey of methods for the evaluation of tissue engineering scaffold permeability. Ann Biomed Eng (2013) 0.84
p53 mutation in breast cancer. Correlation with cell kinetics and cell of origin. J Clin Pathol (2002) 0.84